Price $40.11 |
Market Cap
10.27B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
29.4
|
P/B
2.91
|
P/S
5.18
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
23.2
|
Op. Cash Flow
579.8K
|
FCF
1.9
|
|
Op. Margin
21.10%
|
Net Margin
17.70%
|
ROE
10.40%
|
ROI
8.30%
|
|
ROA
5.60%
|
EPS Growth
-34.60%
|
Current Ratio
2.5
|
Debt/Equity
42.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc (INM) | $0.82 | - | - | 3.1M | Strong Buy |
| Collegium Pharmaceutical Inc (COLL) | $22.55 | - | - | 743.4M | Strong Buy |
| Precipio Inc (PRPO) | $0.32 | - | - | 10.7M | Strong Buy |
| Aquestive Therapeutics Inc (AQST) | $1.53 | - | - | 92.3M | Strong Buy |
| Item 9 Labs Corp (INLB) | $0.01 | - | - | 5.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
